immunoglobulin

Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) is an IgG2a, κ antibody inhibitor derived from mice and specifically targets the rat κ immunoglobulin light chain.

Immunoglobulin M heavy chain (IGHM) fragment [Homo sapiens] is a fragment (Gly-Val-Ala-Leu-His-Arg-Pro-Asp-Val-Tyr-Leu-Leu-Pro-Pro-Ala-Arg) on the human immunoglobulin micro heavy chain. Immunoglobulins (Ig) are the antigen recognition molecules of B cell

Immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus] is a fragment on the variable region of the human and mouse immunoglobulin light chain. Immunoglobulins (Ig) are the antigen recognition molecules of B cells. An Ig molecule

Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE)

Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand

Ige decapeptide is a peptide.

Anti-Mouse Kappa Immunoglobulin Light Chain Antibody (HB-58) is an IgG1, κ inhibitor antibody derived from rats, targeting the κ Immunoglobulin Light Chain in mice.

Human Immunoglobulin G, Fc Fragment (IgG, Fc Fragment) is an Fc fragment produced by papain cleavage of IgG, and it does not bind to antigens.

Human Immunoglobulin G (Human IgG) is an immunoglobulin that provides protective and antigen-neutralising functions in humoral immunity, suitable for immunological and inflammatory studies.

Immunoglobulin light chain variable region fragment [Homo sapiens] is a fragment (Phe-Thr-Leu-Lys-Ile-Ser-Arg) on the variable region of the human immunoglobulin light chain.

Human Immunoglobulin M (IgM) is an antibody secreted by the adaptive immune system in response to foreign antigens. It is a primary type of immunoglobulin released into circulation during the early stages of the primary antibody response. Human Immunoglobulin M forms a pentamer comprising five IgG equivalents, with 10 Fab fragments, allowing for 10 antigen binding sites. Additionally, Human Immunoglobulin M acts as a complement (complement) activator.

Sheep Immunoglobulin G (SheepIgG) is a serum immunoglobulin derived from sheep, useful as an immunolabeling and coating protein in various immunoassays, including ELISA.

Human Immunoglobulin G1 (IgG1) is a monoclonal antibody of human origin.

Porcine Immunoglobulin G (PorcineIgG) is a porcine serum immunoglobulin utilized as an immunolabel and coating protein in various immunoassays, including ELISA.

Goat Immunoglobulin G (GoatIgG) is a goat serum immunoglobulin employed in various immunoassays, including ELISA, for use as an immunolabel and coating protein.

Human Immunoglobulin A1 (Human IgA1) is a human IgA1 protein suitable for SDS-PAGE.

Rabbit Immunoglobulin G (RabbitIgG) is a serum immunoglobulin from rabbits, used for immunolabeling and as a coating protein in various immunoassays, such as ELISA.

Human Immunoglobulin G4 (HumanIgG4) is one of the four human IgG subclasses. Unlike other IgG subclasses, IgG4 does not activate complement. In the immune response to filarial parasites, IgG4 may help prevent excessive immune reactions during such infections.

Human Immunoglobulin G3 (HumanIgG3) is an IgG3 that activates complement and exhibits affinity for Fc receptors.

Human immunoglobulin E (HumanIgE) is a crucial mediator in allergic diseases. It is composed of a heavy chain (H) and a light chain (L), with the variable region (V) of the heavy chain believed to play a significant role in its antigen-binding properties.

Human Immunoglobulin A (HumanIgA) is one of the most abundant immunoglobulins in the human body. In serum, IgA primarily exists as a monomer. Human Immunoglobulin A plays a role in mucosal immunity.

Mouse Immunoglobulin G (MouseIgG) is a murine serum immunoglobulin utilized as an immunolabeling and coating protein in various immunoassays, including ELISA.

Human Immunoglobulin G2 (Human IgG2) is a subclass of human IgG antibodies. An IgG2 deficiency can result in a diminished antibody response to bacterial polysaccharides, potentially increasing vulnerability to infections from encapsulated bacteria.

Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease (AD).